Skip to main content
. 2021 Aug 16;39:101089. doi: 10.1016/j.eclinm.2021.101089

Table 1.

General characteristics and clinical features of the study population.

Variables Control (n = 69) DM (n = 69) DR (n = 69) p value

Demographic characteristics
Male, n (%) 53(76·81) 38(55·07) 36(52·17) 0·01 a
Age, years 56·0(54·0,62·0) 53·0(48·0,61·0) 56·0(51·0,65·0) 0·01 b
Research centre, n (%) <0·0001a
Wenzhou 100(100·00) 36(52·17) 48(69·57)
Hefei 0(0·00) 33(47·83) 21(30·43)
Hypertension history, n (%) 0·13 a
No 50(72·46) 36(52·17) 29(42·03)
Yes 19(27·54) 33(47·83) 40(57·97)
Diabetes duration, years NA 8·0(4·0,13·0) 12·0(8·0,17·0) 0·01 c
Lipid-lowering medication, n (%) 0·56 a
No NA 58(84·06) 53(76·81)
Yes NA 8(11·59) 12(17·39)
Missing NA 3(4·35) 4(5·80)
Ever insulin therapy, n (%) 0·17 a
No NA 46(66·67) 55(79·71)
Yes NA 19(27·54) 10(14·49)
Missing NA 4(5·80) 4(5·80)
Anthropometric Examination
Body Mass Index, kg/m2 24·47(23·36,26·73) 23·91(22·22,26·40) 24·10(22·41,26·64) 0·52 b
Systolic blood pressure, mmHg NA 124(118,139) 135(122,148) 0·01 c
Diastolic blood pressure, mmHg NA 79(74,86) 76(70,85) 0·20 c
Biological measurements
Glycated haemoglobin,% 5·70(5·40,6·05) 9·90(8·30,11·80) 9·80(8·90,10·90) <0·0001 b
Fasting plasma glucose, mmol/L 5·39(5·11,6·06) 8·35(6·92,12·00) 8·50(6·31,10·17) <0·0001 b
Triglyceride, mmol/L 1·95(1·48,2·99) 1·61(1·04,2·17) 1·39(1·03,1·86) <0·0001 b
Total cholesterol, mmol/L 5·00 ± 0·93 4·72 ± 1·14 4·51 ± 1·40 0·05 d
Low density lipoprotein, mmol/L 2·82 ± 0·78 2·65 ± 1·00 2·55 ± 1·07 0·25 d
High density lipoprotein, mmol/L 1·09(0·98,1·26) 1·02(0·80,1·34) 1·09(0·86,1·32) 0·20 b

Control: healthy control; DM: type 2 diabetic patients without diabetic retinopathy; DR: type 2 diabetic patients with diabetic retinopathy; NA: not applicable.

Data were presented as mean ± standard deviation for normal or similar normal distributed variables, number (percentage) for categorical variables, or median (25th,75th percentiles) for variables having skewed distribution.

a

p values were derived from Chi-Square tests.

b

p values for Kruskal-Wallis H tests.

c

p values for Mann–Whitney U tests.

d

p values for F tests (ANOVA).